Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer

Journal of Urology

Volumn 192, Issue 1, 2014, Pages 75-81

  Filson, Christopher P ^a   Schroeck, Florian R ^b   Ye, Zaojun ^c   Wei, John T ^c   Hollenbeck, Brent K ^c   Miller, David C ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Medicare; physician's practice patterns; prostate; prostatic neoplasms; SEER program

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER LOCALIZATION; CANCER REGISTRY; COMORBIDITY; DISEASE SEVERITY; DISEASE SURVEILLANCE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REIMBURSEMENT; SOCIAL STATUS; TERMINAL CARE; WATCHFUL WAITING; ADULT; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CLINICAL PRACTICE; DEMOGRAPHY; HEALTH SURVEY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; TREATMENT OUTCOME; PATHOLOGY; PROSTATIC NEOPLASMS; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

AGED; HUMANS; MALE; MEDICARE; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PROSTATIC NEOPLASMS; UNITED STATES; WATCHFUL WAITING;

EID: 84902553737     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.01.105     Document Type: Article

References (26)

1. A. Bill-Axelson, L. Holmberg, and M. Ruutu et al. Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708
2. G.L. Lu-Yao, P.C. Albertsen, and D.F. Moore et al. Outcomes of localized prostate cancer following conservative management JAMA 302 2009 1202
3. H.G. Welch, and W.C. Black Overdiagnosis in cancer J Natl Cancer Inst 102 2010 605
4. M.R. Cooperberg, P.R. Carroll, and L. Klotz Active surveillance for prostate cancer: progress and promise J Clin Oncol 29 2011 3669
5. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117
6. I. Thompson, J.B. Thrasher, and G. Aus et al. Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106
7. E.S. Fisher The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care Ann Intern Med 138 2003 273
8. A.B. Nattinger, T.L. McAuliffe, and M.M. Schapira Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research J Clin Epidemiol 50 1997 939
9. C. Zippin, D. Lum, and B.F. Hankey Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute Cancer 76 1995 2343
10. C.N. Klabunde, A.L. Potosky, and J.M. Legler et al. Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258
11. A.V. Diez-Roux, S.S. Merkin, and D. Arnett et al. Neighborhood of residence and incidence of coronary heart disease N Engl J Med 345 2001 99
12. A.V. D'Amico, R. Whittington, and S.B. Malkowicz et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969
13. J.E. Wennberg, and M.M. Cooper The Dartmouth Atlas of Health Care 1996 American Hospital Publishing Chicago
14. F.R. Schroeck, S.R. Kaufman, and B.L. Jacobs et al. Technology diffusion and diagnostic testing for prostate cancer J Urol 190 2013 1715
15. Dartmouth Institute for Health Policy and Clinical Practice: The Dartmouth Atlas of Health Care. Available at http://www.dartmouthatlas.org. Accessed May 2013.
16. H.P. Huber On the problem of variance-analytical reliability estimation in correlated measurement errors Arch Gesamte Psychol 119 1967 288
17. H. White Maximum likelihood estimation of misspecified models Econometrica 50 1982 1
18. A.S. Hamilton, X.C. Wu, and J. Lipscomb et al. Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer J Natl Cancer Inst Monogr 2012 2012 213
19. W. Underwood, S. DeMonner, and P. Ubel et al. Racial/ethnic disparities in the treatment of localized/regional prostate cancer J Urol 171 2004 1504
20. C.N. Klabunde, A.L. Potosky, and L.C. Harlan et al. Trends and black/white differences in treatment for nonmetastatic prostate cancer Med Care 36 1998 1337
21. D. Sundi, A.E. Ross, and E.B. Humphreys et al. African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them? J Clin Oncol 31 2013 2991
22. A.A. Aizer, J.J. Paly, and A.L. Zietman et al. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer J Clin Oncol 30 2012 3071
23. F.J. Fowler, M. McNaughton Collins, and P.C. Albertsen et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer JAMA 283 2000 3217
24. T.L. Jang, J.E. Bekelman, and Y. Liu et al. Physician visits prior to treatment for clinically localized prostate cancer Arch Intern Med 170 2010 440
25. S.P. Elliott, D.P. Johnson, and S.L. Jarosek et al. Bias due to missing SEER data in D'Amico risk stratification of prostate cancer J Urol 187 2012 2026
26. D.C. Miller, D.S. Murtagh, and R.S. Suh et al. Establishment of a urological surgery quality collaborative J Urol 184 2010 2485